Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Analgesia and Fast-Track Surgery in Colon Carcinoma
ChiCTR-IPR-15005931Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone, flurbiprofen axetil, levobupivacaine, celecoxib, sufentanil and 2 more in colon cancer (3 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Total hospital stay. Planned start Feb 2015; status: not yet recruiting.
02
Drugs
dexamethasoneflurbiprofen axetillevobupivacainecelecoxibsufentanil
03
Conditions
colon cancer
Beyond the preview
Go deeper on ChiCTR-IPR-15005931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005931.